193 related articles for article (PubMed ID: 20927744)
1. Interval debulking surgery for advanced epithelial ovarian cancer.
Tangjitgamol S; Manusirivithaya S; Laopaiboon M; Lumbiganon P; Bryant A
Cochrane Database Syst Rev; 2010 Oct; (10):CD006014. PubMed ID: 20927744
[TBL] [Abstract][Full Text] [Related]
2. Interval debulking surgery for advanced epithelial ovarian cancer.
Tangjitgamol S; Manusirivithaya S; Laopaiboon M; Lumbiganon P; Bryant A
Cochrane Database Syst Rev; 2013 Apr; 4(4):CD006014. PubMed ID: 23633332
[TBL] [Abstract][Full Text] [Related]
3. Interval debulking surgery for advanced epithelial ovarian cancer.
Tangjitgamol S; Manusirivithaya S; Laopaiboon M; Lumbiganon P; Bryant A
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD006014. PubMed ID: 26747297
[TBL] [Abstract][Full Text] [Related]
4. Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.
Bryant A; Hiu S; Kunonga PT; Gajjar K; Craig D; Vale L; Winter-Roach BA; Elattar A; Naik R
Cochrane Database Syst Rev; 2022 Sep; 9(9):CD015048. PubMed ID: 36161421
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer.
Coleridge SL; Bryant A; Kehoe S; Morrison J
Cochrane Database Syst Rev; 2021 Feb; 2(2):CD005343. PubMed ID: 33543776
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer.
Coleridge SL; Bryant A; Lyons TJ; Goodall RJ; Kehoe S; Morrison J
Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684686
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.
Winter-Roach BA; Kitchener HC; Lawrie TA
Cochrane Database Syst Rev; 2012 Mar; 3(3):CD004706. PubMed ID: 22419298
[TBL] [Abstract][Full Text] [Related]
8. Ultra-radical (extensive) surgery versus standard surgery for the primary cytoreduction of advanced epithelial ovarian cancer.
Hiu S; Bryant A; Gajjar K; Kunonga PT; Naik R
Cochrane Database Syst Rev; 2022 Aug; 8(8):CD007697. PubMed ID: 36041232
[TBL] [Abstract][Full Text] [Related]
9. Surgical cytoreduction for recurrent epithelial ovarian cancer.
Al Rawahi T; Lopes AD; Bristow RE; Bryant A; Elattar A; Chattopadhyay S; Galaal K
Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD008765. PubMed ID: 23450588
[TBL] [Abstract][Full Text] [Related]
10. Angiogenesis inhibitors for the treatment of ovarian cancer.
Gaitskell K; Martinek I; Bryant A; Kehoe S; Nicum S; Morrison J
Cochrane Database Syst Rev; 2011 Sep; (9):CD007930. PubMed ID: 21901715
[TBL] [Abstract][Full Text] [Related]
11. Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer.
Jaaback K; Johnson N; Lawrie TA
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD005340. PubMed ID: 26755441
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancer.
Rydzewska L; Tierney J; Vale CL; Symonds PR
Cochrane Database Syst Rev; 2012 Dec; 12(12):CD007406. PubMed ID: 23235641
[TBL] [Abstract][Full Text] [Related]
13. DNA-repair pathway inhibitors for the treatment of ovarian cancer.
Martinek I; Haldar K; Gaitskell K; Bryant A; Nicum S; Kehoe S; Morrison J
Cochrane Database Syst Rev; 2010 Jun; (6):CD007929. PubMed ID: 20556786
[TBL] [Abstract][Full Text] [Related]
14. Advanced Ovarian Cancer: Primary or Interval Debulking? Five Categories of Patients in View of the Results of Randomized Trials and Tumor Biology: Primary Debulking Surgery and Interval Debulking Surgery for Advanced Ovarian Cancer.
Makar AP; Tropé CG; Tummers P; Denys H; Vandecasteele K
Oncologist; 2016 Jun; 21(6):745-54. PubMed ID: 27009938
[TBL] [Abstract][Full Text] [Related]
15. Optimal number of neoadjuvant chemotherapy cycles prior to interval debulking surgery in advanced epithelial ovarian cancer: a systematic review and meta-analysis of progression-free survival and overall survival.
Coada CA; Dondi G; Ravegnini G; Di Costanzo S; Tesei M; Fiuzzi E; Di Stanislao M; Giunchi S; Zamagni C; Bovicelli A; Hrelia P; Angelini S; De Iaco P; Perrone AM
J Gynecol Oncol; 2023 Nov; 34(6):e82. PubMed ID: 37743060
[TBL] [Abstract][Full Text] [Related]
16. Chemoradiation for advanced primary vulval cancer.
Shylasree TS; Bryant A; Howells RE
Cochrane Database Syst Rev; 2011 Apr; 2011(4):CD003752. PubMed ID: 21491387
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of follow-up strategies for patients with epithelial ovarian cancer following completion of primary treatment.
Clarke T; Galaal K; Bryant A; Naik R
Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD006119. PubMed ID: 25198378
[TBL] [Abstract][Full Text] [Related]
18. The role of neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer: a systematic review and meta-analysis of randomized controlled trials and observational studies.
Qin M; Jin Y; Ma L; Zhang YY; Pan LY
Oncotarget; 2018 Feb; 9(9):8614-8628. PubMed ID: 29492221
[TBL] [Abstract][Full Text] [Related]
19. Palliative surgery versus medical management for bowel obstruction in ovarian cancer.
Kucukmetin A; Naik R; Galaal K; Bryant A; Dickinson HO
Cochrane Database Syst Rev; 2010 Jul; 2010(7):CD007792. PubMed ID: 20614464
[TBL] [Abstract][Full Text] [Related]
20. Hyperthermic Intraperitoneal Chemotherapy (HIPEC): New Approaches and Controversies on the Treatment of Advanced Epithelial Ovarian Cancer-Systematic Review and Meta-Analysis.
Della Corte L; Conte C; Palumbo M; Guerra S; Colacurci D; Riemma G; De Franciscis P; Giampaolino P; Fagotti A; Bifulco G; Scambia G
J Clin Med; 2023 Nov; 12(22):. PubMed ID: 38002626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
